Resting-state EEG delta and alpha power predict response to cognitive behavioral therapy in depression: a Canadian biomarker integration network for depression study

Resting-state EEG delta and alpha power predict response to cognitive behavioral therapy in depression: a Canadian biomarker integration network for depression study

Abstract Cognitive behavioral therapy (CBT) is often recommended as a first-line treatment in depression. However, access to CBT remains limited, and up to 50% of patients do not benefit from this therapy. Identifying biomarkers that can predict which patients will respond to CBT may assist in desig...

Full description

Bibliographic Details
Main Authors:	Benjamin Schwartzmann, Lena C. Quilty, Prabhjot Dhami, Rudolf Uher, Timothy A. Allen, Stefan Kloiber, Raymond W. Lam, Benicio N. Frey, Roumen Milev, Daniel J. Müller, Claudio N. Soares, Jane A. Foster, Susan Rotzinger, Sidney H. Kennedy, Faranak Farzan
Format:	Article
Language:	English
Published:	Nature Portfolio 2023-05-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-023-35179-4

Similar Items

Alterations in the neural correlates of affective inhibitory control following cognitive behavioral therapy for depression: A Canadian biomarker integration network for depression (CAN-BIND) study
by: Prabhjot Dhami, et al.
Published: (2022-12-01)

Modulation of neural oscillations in escitalopram treatment: a Canadian biomarker integration network in depression study
by: Benjamin Schwartzmann, et al.
Published: (2024-10-01)

Baseline low-frequency EEG oscillations are associated with therapeutic response to theta burst stimulation augmented with cognitive training in youth depression
by: Benjamin Schwartzmann, et al.
Published: (2023-01-01)

Investigating how TMS-evoked potentials relate to individual depressive symptoms in Depression
by: Prabhjot Dhami, et al.
Published: (2025-01-01)

Rasch analyses of the Quick Inventory of Depressive Symptomatology Self-Report in neurodegenerative and major depressive disorders
by: Anthony L. Vaccarino, et al.
Published: (2023-06-01)

Correction: Replication of machine learning methods to predict treatment outcome with antidepressant medications in patients with major depressive disorder from STAR*D and CAN-BIND-1.
by: John-Jose Nunez, et al.
Published: (2024-01-01)

Rhythmicity of sleep and clinical outcomes in major depressive disorder: A CAN-BIND-1 report
by: Manish Dama, et al.
Published: (2022-07-01)

Neurophysiological impact of theta burst stimulation followed by cognitive exercise in treatment of youth depression
by: Prabhjot Dhami, et al.
Published: (2022-12-01)

Baseline markers of cortical excitation and inhibition predict response to theta burst stimulation treatment for youth depression
by: Prabhjot Dhami, et al.
Published: (2023-11-01)

Olfactory Functioning and Depression: A Systematic Review
by: Hannah Taalman, et al.
Published: (2017-09-01)

Functional neuroimaging biomarkers of anhedonia response to escitalopram plus adjunct aripiprazole treatment for major depressive disorder
by: Sophie R. Vaccarino, et al.
Published: (2024-01-01)

TMS-Induced Changes in Global Brain Dynamics: Insights from EEG Microstate Analysis
by: Amin Kabir, et al.
Published: (2025-01-01)

Agitation Predicts Response of Depression to Botulinum Toxin Treatment in a Randomized Controlled Trial: the work of M. Alex Wollmer, et al. (2014)
by: Roumen eMilev
Published: (2015-04-01)

Pretreatment anxious depression as a predictor of side effect frequency and severity in escitalopram and aripiprazole adjunctive therapy
by: Caroline W. Espinola, et al.
Published: (2022-05-01)

Endocannabinoid concentrations in major depression: effects of childhood maltreatment and relation to hippocampal volume
by: Raegan Mazurka, et al.
Published: (2024-10-01)

Alpha peak activity in resting-state EEG is associated with depressive score
by: Peng Zhou, et al.
Published: (2023-03-01)

A resting state EEG study on depressed persons with suicidal ideation
by: Francesco Amico, et al.
Published: (2023-06-01)

Effects of CYP2C19 and CYP2D6 gene variants on escitalopram and aripiprazole treatment outcome and serum levels: results from the CAN-BIND 1 study
by: Farhana Islam, et al.
Published: (2022-09-01)

The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression and/or Generalized Anxiety Disorder: Protocol for a Phase 1, Open-Label Study
by: Chinna Meyyappan, Arthi, et al.
Published: (2020-06-01)

Association of resting-state EEG with suicidality in depressed patients: a systematic review
by: Fatemeh Shamsi, et al.
Published: (2025-01-01)

Resting-state EEG networks characterized by intramodular and global hyperconnectivity in depressive sample
by: A. Komarova, et al.
Published: (2022-06-01)

Assessing remission in major depressive disorder using a functional-structural data fusion pipeline: A CAN-BIND-1 study
by: Sondos Ayyash, et al.
Published: (2024-06-01)

Personalized relapse prediction in patients with major depressive disorder using digital biomarkers
by: Srinivasan Vairavan, et al.
Published: (2023-10-01)

Exposure to Depression Memes on Social Media Increases Depressive Mood and It Is Moderated by Self-Regulation: Evidence From Self-Report and Resting EEG Assessments
by: Atakan M. Akil, et al.
Published: (2022-06-01)

Resting-State EEG Alterations of Practice-Related Spectral Activity and Connectivity Patterns in Depression
by: Elisa Tatti, et al.
Published: (2024-09-01)

A pilot study of machine learning of resting-state EEG and depression in Parkinson’s disease
by: Arturo I. Espinoza, et al.
Published: (2022-01-01)

EEG Resting-State Large-Scale Brain Network Dynamics Are Related to Depressive Symptoms
by: Alena Damborská, et al.
Published: (2019-08-01)

Resting-state EEG-based convolutional neural network for the diagnosis of depression and its severity
by: Mengqian Li, et al.
Published: (2022-10-01)

Microbial Ecosystem Therapeutic-2 Intervention in People With Major Depressive Disorder and Generalized Anxiety Disorder: Phase 1, Open-Label Study
by: Arthi Chinna Meyyappan, et al.
Published: (2022-01-01)

Atypical Temporal Dynamics of Resting State Shapes Stimulus-Evoked Activity in Depression—An EEG Study on Rest–Stimulus Interaction
by: Annemnarie Wolff, et al.
Published: (2019-10-01)

Predicting escitalopram treatment response from pre-treatment and early response resting state fMRI in a multi-site sample: A CAN-BIND-1 report
by: Jacqueline K. Harris, et al.
Published: (2022-01-01)

Corrigendum: Exposure to depression memes on social media increases depressive mood and it is moderated by self-regulation: Evidence from self-report and resting EEG assessments
by: Atakan M. Akil, et al.
Published: (2023-02-01)

Accelerated brain aging in major depressive disorder and antidepressant treatment response: A CAN-BIND report
by: Pedro L. Ballester, et al.
Published: (2021-01-01)

Delta and theta eeg activity during resting state is altered in patients affected by major depression
by: C. Spironelli, et al.
Published: (2021-04-01)

Resting and TMS-EEG markers of treatment response in major depressive disorder: A systematic review
by: Rebecca Strafella, et al.
Published: (2022-08-01)

A standardized workflow for long-term longitudinal actigraphy data processing using one year of continuous actigraphy from the CAN-BIND Wellness Monitoring Study
by: Anastasiya Slyepchenko, et al.
Published: (2023-09-01)

Insulin Resistance as a Shared Pathogenic Mechanism Between Depression and Type 2 Diabetes
by: Natalia de M. Lyra e Silva, et al.
Published: (2019-02-01)

A Pilot Study Investigating the Effect of Music-Based Intervention on Depression and Anhedonia
by: Thenille Braun Janzen, et al.
Published: (2019-05-01)

Data and alternative models describing the associations among non-infection pandemic stress, event-related rumination, depression, and anxiety
by: Mianzhi Hu, et al.
Published: (2023-02-01)

Salivary cortisol during memory encoding in pregnancy predicts postpartum depressive symptoms: a longitudinal study
by: Marissa E. Williams, et al.